Literature DB >> 14749186

The human parainfluenza virus type 3 (HPIV 3) C protein inhibits viral transcription.

Achut G Malur1, Michael A Hoffman, Amiya K Banerjee.   

Abstract

The C protein of human parainfluenza virus type 3 (HPIV 3), like other paramyxovirus C proteins, is synthesized from an alternate open reading frame (ORF) encoded within the phosphoprotein (P) mRNA, in addition, to two other proteins, namely D and V, which arise from the same mRNA by a process of transcriptional editing. The precise role of the C, D, and V proteins in viral transcription and replication, and their interaction, if any, with other viral proteins remains unknown. To ascertain the role of the C protein, we have examined its effect on transcription using an HPIV 3 minigenome construct and monitoring the luciferase reporter gene expression. Our results demonstrate that the HPIV 3 C protein effectively inhibits minigenome transcription in a dose-dependent manner. Interestingly, the Sendai virus (Se-V) C protein was also capable of inducing an inhibitory effect on the HPIV 3 minigenome transcription, thus demonstrating a heterologous interaction. A coiled-coil motif within the C protein has been identified, and a deletion mutant within this motif abrogated the inhibitory effect significantly thereby implying that oligomerization of the C protein may be involved in inhibition of transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749186     DOI: 10.1016/j.virusres.2003.11.009

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  20 in total

1.  Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction.

Authors:  Kay Childs; Richard Randall; Stephen Goodbourn
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  The regulation of type I interferon production by paramyxoviruses.

Authors:  Stephen Goodbourn; Richard E Randall
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

3.  Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Authors:  Niraj K Shil; Swechha M Pokharel; Amiya K Banerjee; Michael Hoffman; Santanu Bose
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 4.  Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Authors:  Denis Gerlier; Douglas S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2011-09       Impact factor: 11.056

Review 5.  Paramyxovirus activation and inhibition of innate immune responses.

Authors:  Griffith D Parks; Martha A Alexander-Miller
Journal:  J Mol Biol       Date:  2013-09-20       Impact factor: 5.469

Review 6.  Pathogenesis of acute respiratory illness caused by human parainfluenza viruses.

Authors:  Henrick Schomacker; Anne Schaap-Nutt; Peter L Collins; Alexander C Schmidt
Journal:  Curr Opin Virol       Date:  2012-03-03       Impact factor: 7.090

7.  Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study.

Authors:  Jeremy Seto; Liang Qiao; Carolin A Guenzel; Sa Xiao; Megan L Shaw; Fernand Hayot; Stuart C Sealfon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

8.  Viral protein requirements for assembly and release of human parainfluenza virus type 3 virus-like particles.

Authors:  Megan K Bracken; Brandon C Hayes; Suresh R Kandel; Deja Scott-Shemon; Larissa Ackerson; Michael A Hoffman
Journal:  J Gen Virol       Date:  2016-03-09       Impact factor: 3.891

9.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication.

Authors:  Hongxia Mao; Santanu Chattopadhyay; Amiya K Banerjee
Journal:  Virology       Date:  2009-09-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.